Investing.com -- BMO Capital upgraded Ingevity (NYSE:NGVT) Corporation to Outperform and raised its price target to $65 in a note Wednesday, citing strong earnings and free cash flow (FCF) growth outlook for 2025 and 2026.
Analysts believe the stock now offers an attractive risk-reward profile, especially with activist investor Vision One involved.
BMO had previously remained cautious due to uncertainty around a new CEO and potential auto-related tariffs.
However, analysts now believe that “with an activist (Vision One) now in NGVT, we believe investors are better protected from downside risks and should enjoy the coming lift tied to NGVT's improved EPS/FCF.”
The firm expects a significant earnings inflection beginning in 2025. “We see EBITDA conservatively jumping 12% to $406mn,” BMO analysts wrote, aligning with management’s guidance of $400-$415mn.
They believe the growth will be driven by the stability in Performance Materials, the recovery in the Performance Chemicals (PC) segment, following asset closures and a shift away from crude tall oil (CTO), and modest improvements in the Advanced Polymer Technologies (APT) segment.
By 2026, BMO forecasts EBITDA to rise another 9%, supported by a return to growth in Perf Mats, an improving auto sector, and continued strength in PC and APT. As a result, EPS is projected to climb from $3.58 in 2024 to $4.78 in 2025 (+33%) and $5.77 in 2026 (+21%).
With a 7.7x multiple on projected 2026 EBITDA of $443mn, BMO sees substantial upside potential for the stock.
Related Articles
Ingevity Corporation 'EPS/FCF growth to drive stock': BMO Capital
Ghana's cocoa arrivals surge 70% due to improved harvest, smuggling crackdown - Bloomberg
Warner Bros Discovery to offer sports, news content free on Max platform
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.